We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck KGaA Halts Development Of Parkinson's Drug
Merck KGaA Halts Development Of Parkinson's Drug
June 23, 2006
Merck KGaA will suspend development of a new treatment for Parkinson’s disease after clinical trials failed to confirm the results of earlier studies, the company said.